Interest in biologic therapies continues to grow in sports medicine and orthopedic care. In particular, clinicians and researchers continue to study platelet-rich plasma (PRP) as a potential option for musculoskeletal conditions.
Recently, Lee Mancini, MD, associate professor of family medicine and community health, discussed PRP in a feature published by the University of Massachusetts Medical School’s Science for Living program.
According to Dr. Mancini, physicians and researchers continue to evaluate platelet-rich plasma injections in the context of conditions such as osteoarthritis and tendinopathies.
Growing Interest in Regenerative Medicine
Over the past decade, physicians have shown increasing interest in regenerative medicine technologies. These approaches often focus on biologic materials derived from the patient’s own body.
For example, platelet-rich plasma is prepared from a patient’s blood using centrifugation technology. This process concentrates platelets within plasma, creating an autologous biologic preparation.
Because platelets contain signaling proteins and growth factors involved in natural biological processes, researchers continue to study their role in tissue response and repair.
Professional Organizations Evaluate the Evidence
As interest in regenerative medicine grows, professional medical organizations have begun reviewing the available scientific literature.
For example, the American Medical Society for Sports Medicine (AMSSM) published a position statement to help physicians evaluate regenerative medicine technologies, including platelet-rich plasma.
These guidelines encourage clinicians to review current research and evaluate emerging biologic treatments using evidence-based standards.
Ongoing Research in PRP
Researchers continue to study platelet-rich plasma across several musculoskeletal conditions. These areas of investigation include:
osteoarthritis
tendon injuries and tendinopathies
ligament conditions
musculoskeletal soft-tissue disorders
Although research continues to expand, clinicians typically review the available evidence and clinical guidelines when considering biologic therapies.
Learn More
To read the full discussion from Dr. Mancini, visit the original article published by UMass Medical School:
Science for Living: Lee Mancini discusses platelet-rich plasma injections for osteoarthritis and tendinopathies
(umassmed.edu)